ScottWLeeMD

Endocrinology • Loma Linda, CA

Diabetes, Lipid Metabolism

Clinical Professor of Medicine, Loma Linda University

Join to view full profile

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile

Already have an account?

Office
11370 Anderson St
Loma Linda, CA 92354
Phone+1 909-558-2870

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1998
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1993 - 1996
Northwestern University The Feinberg School of MedicineClass of 1993

Certifications & Licensure

CA State Medical License 1996 - 2026
WI State Medical License 1994 - 1997
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes Start of enrollment: 2005 Jun 01
Completed
Not Applicable
Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration Start of enrollment: 2002 Jun 01
Completed
Phase 3
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy Start of enrollment: 2007 Jan 01
Completed
Not Applicable
An Inpatient Performance Evaluation of a New Subcutaneous Glucose Sensor Start of enrollment: 2010 Apr 01
Completed
Not Applicable
United Kingdom User Evaluation, MiniMed Paradigm® X54 System Start of enrollment: 2009 Jan 01
Completed
Phase 4
A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use Start of enrollment: 2011 Nov 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Discovery of NFκB2-Coordinated Dual Regulation of Mitochondrial and Nuclear Genomes Leads to an Effective Therapy for Acute Myeloid Leukemia.
Yi Xu, David J Baylink, Jeffrey Xiao, Lily Tran, Vinh Nguyen
International Journal of Molecular Sciences. 2024-08-05
6 citations
Safety and Glycemic Outcomes During the MiniMedAdvanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes.
Catherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, Kevin B Kaiserman, Jennifer L Sherr
Diabetes Technology & Therapeutics. 2023-11-01
1 citations
Safety Event Outcomes and Glycemic Control with a Hybrid Closed-Loop System Used by Chinese Adolescents and Adults with Type 1 Diabetes Mellitus.
Yu Pei, Weijian Ke, Jing Lu, Yi Lin, Zhijian Zhang
Diabetes Technology & Therapeutics. 2023-10-01

Professional Memberships

American Association of Clinical Endocrinologists - AACE
Member